Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium tuberculosis | 9 | 2024 | 90 | 4.230 |
Why?
|
| Tuberculosis | 8 | 2024 | 63 | 2.880 |
Why?
|
| Bacterial Proteins | 4 | 2024 | 540 | 1.290 |
Why?
|
| Macrophages | 5 | 2024 | 439 | 1.060 |
Why?
|
| Mycobacterium bovis | 3 | 2022 | 15 | 0.990 |
Why?
|
| Mycobacterium Infections | 1 | 2022 | 16 | 0.860 |
Why?
|
| Antigens, Bacterial | 2 | 2020 | 132 | 0.810 |
Why?
|
| Arginine | 1 | 2018 | 73 | 0.630 |
Why?
|
| Oxidative Stress | 2 | 2024 | 938 | 0.580 |
Why?
|
| Phagosomes | 3 | 2019 | 30 | 0.540 |
Why?
|
| BCG Vaccine | 4 | 2022 | 10 | 0.440 |
Why?
|
| GTP-Binding Proteins | 2 | 2011 | 60 | 0.430 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2009 | 4 | 0.350 |
Why?
|
| Mice | 7 | 2024 | 5913 | 0.290 |
Why?
|
| Microbial Viability | 1 | 2024 | 37 | 0.240 |
Why?
|
| Oxidoreductases | 1 | 2024 | 87 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 1609 | 0.210 |
Why?
|
| Animals | 8 | 2024 | 15081 | 0.210 |
Why?
|
| Vaccination | 2 | 2022 | 288 | 0.210 |
Why?
|
| Crystallography, X-Ray | 1 | 2022 | 265 | 0.200 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 1371 | 0.200 |
Why?
|
| Drug Discovery | 1 | 2022 | 82 | 0.200 |
Why?
|
| Host-Pathogen Interactions | 2 | 2022 | 186 | 0.200 |
Why?
|
| Lung | 1 | 2024 | 446 | 0.190 |
Why?
|
| Drug Design | 1 | 2022 | 162 | 0.190 |
Why?
|
| Immunization, Secondary | 1 | 2020 | 8 | 0.190 |
Why?
|
| Virulence | 2 | 2019 | 223 | 0.190 |
Why?
|
| Guinea Pigs | 1 | 2020 | 145 | 0.180 |
Why?
|
| Interferon-gamma | 2 | 2011 | 250 | 0.170 |
Why?
|
| Necrosis | 1 | 2019 | 49 | 0.170 |
Why?
|
| Chemokines | 1 | 2019 | 97 | 0.160 |
Why?
|
| Antitubercular Agents | 1 | 2018 | 28 | 0.160 |
Why?
|
| Sulfhydryl Compounds | 1 | 2018 | 47 | 0.160 |
Why?
|
| Vaccines | 1 | 2019 | 55 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 67 | 0.160 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2018 | 77 | 0.160 |
Why?
|
| Mycobacterium smegmatis | 2 | 2015 | 7 | 0.150 |
Why?
|
| Flow Cytometry | 1 | 2018 | 399 | 0.150 |
Why?
|
| Humans | 6 | 2024 | 37093 | 0.140 |
Why?
|
| DNA Damage | 1 | 2018 | 352 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 461 | 0.130 |
Why?
|
| Lymph | 1 | 2015 | 1 | 0.130 |
Why?
|
| Lymphatic Vessels | 1 | 2015 | 6 | 0.130 |
Why?
|
| Lymph Nodes | 1 | 2015 | 67 | 0.130 |
Why?
|
| Antioxidants | 1 | 2018 | 416 | 0.130 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 626 | 0.120 |
Why?
|
| Mycolic Acids | 1 | 2014 | 1 | 0.120 |
Why?
|
| 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | 1 | 2014 | 1 | 0.120 |
Why?
|
| Tuberculosis Vaccines | 1 | 2013 | 1 | 0.120 |
Why?
|
| Proteome | 1 | 2015 | 144 | 0.120 |
Why?
|
| Vaccines, Synthetic | 1 | 2013 | 72 | 0.110 |
Why?
|
| Lysosomes | 2 | 2011 | 91 | 0.110 |
Why?
|
| Immunity, Innate | 2 | 2011 | 149 | 0.100 |
Why?
|
| Aging | 1 | 2015 | 664 | 0.090 |
Why?
|
| SNARE Proteins | 1 | 2009 | 7 | 0.090 |
Why?
|
| Intracellular Membranes | 1 | 2009 | 38 | 0.090 |
Why?
|
| Protein Structure, Secondary | 1 | 2009 | 183 | 0.080 |
Why?
|
| Protein Transport | 1 | 2009 | 302 | 0.080 |
Why?
|
| Protein Binding | 1 | 2009 | 972 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2009 | 1518 | 0.060 |
Why?
|
| Female | 1 | 2024 | 20969 | 0.060 |
Why?
|
| Granuloma | 1 | 2022 | 26 | 0.050 |
Why?
|
| Cell Death | 1 | 2022 | 267 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2009 | 1908 | 0.050 |
Why?
|
| Mesentery | 1 | 2015 | 9 | 0.030 |
Why?
|
| Connexins | 1 | 2015 | 13 | 0.030 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2015 | 17 | 0.030 |
Why?
|
| Glycosylation | 1 | 2015 | 100 | 0.030 |
Why?
|
| Gap Junctions | 1 | 2015 | 38 | 0.030 |
Why?
|
| Glycocalyx | 1 | 2015 | 36 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2015 | 67 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2015 | 245 | 0.030 |
Why?
|
| Microbiological Techniques | 1 | 2014 | 11 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2015 | 75 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2015 | 86 | 0.030 |
Why?
|
| Cell Wall | 1 | 2014 | 53 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 150 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2014 | 109 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2014 | 105 | 0.030 |
Why?
|
| Homeostasis | 1 | 2015 | 188 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 119 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2013 | 159 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 1180 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 1568 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2015 | 308 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 356 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2011 | 6 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 928 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2011 | 69 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2014 | 808 | 0.020 |
Why?
|
| Autophagy | 1 | 2011 | 116 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 243 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 431 | 0.020 |
Why?
|
| Peptides | 1 | 2011 | 320 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 3483 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 1354 | 0.020 |
Why?
|
| Male | 1 | 2015 | 20025 | 0.010 |
Why?
|